In vitro, classical complement activation differs by disease severity and between SARS-CoV-2 antigens

Rachel E Lamerton, Edith Marcial Juarez, Sian E Faustini, Marisol E Perez-Toledo, Margaret Goodall, Sian E Jossi, Maddy L Newby, Iain Chapple, Thomas Dietrich, Tonny Veenith, Adrian M Shields, Lorraine Harper, Ian R Henderson, Julie Rayes, David C Wraith, Steve P Watson, Max Crispin, Mark T Drayson, Alex G Richter, Adam F Cunningham

Research output: Working paper/PreprintPreprint

Fingerprint

Dive into the research topics of 'In vitro, classical complement activation differs by disease severity and between SARS-CoV-2 antigens'. Together they form a unique fingerprint.

Medicine & Life Sciences